Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
57.82 USD | -0.11% | -11.18% | -30.55% |
05-09 | Oppenheimer Adjusts Cytokinetics Price Target to $106 From $107, Maintains Outperform Rating | MT |
05-08 | Cytokinetics Q1 Net Loss Narrows, Revenue Declines | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CYTOKINETICS, INCORPORATED | Bio Therapeutic Drugs | -0.17% | -11.18% | -30.55% | +48.86% | +455.90% | 6.07B |
- Stock Market
- Equities
- CYTK Stock
- Charts Cytokinetics, Incorporated
- Relative Strength Chart